1-O-HEXADECYL-(7,7,8,8-D4)-2-O-ACETYL-SN-GLYCERYL-3-PHOSPHORYLCHOLINE
![]() |
- $25 - $186
- Product name: 1-O-HEXADECYL-(7,7,8,8-D4)-2-O-ACETYL-SN-GLYCERYL-3-PHOSPHORYLCHOLINE
- CAS: 211106-54-6
- MF: C26H50D4NO7P
- MW: 527.71
- EINECS:
- MDL Number:MFCD00084830
- Synonyms:PAF C-16-D4;1-O-HEXADECYL-(7,7,8,8-D4)-2-O-ACETYL-SN-GLYCERYL-3-PHOSPHORYLCHOLINE;HVAUUPRFYPCOCA-VGOTWLLUSA-N
3 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 100μg
- 500μg
- 1mg
- ManufacturerCayman Chemical
- Product number360900
- Product descriptionPAF C-16-d4 ≥99% deuterated forms (d1-d4)
- Packaging100μg
- Price$25
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number360900
- Product descriptionPAF C-16-d4 ≥99% deuterated forms (d1-d4)
- Packaging500μg
- Price$107
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number360900
- Product descriptionPAF C-16-d4 ≥99% deuterated forms (d1-d4)
- Packaging1mg
- Price$186
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 360900 | PAF C-16-d4 ≥99% deuterated forms (d1-d4) | 100μg | $25 | 2024-03-01 | Buy |
Cayman Chemical | 360900 | PAF C-16-d4 ≥99% deuterated forms (d1-d4) | 500μg | $107 | 2024-03-01 | Buy |
Cayman Chemical | 360900 | PAF C-16-d4 ≥99% deuterated forms (d1-d4) | 1mg | $186 | 2024-03-01 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMF: 10 mg/ml,DMSO: 10 mg/ml,Ethanol: 10 mg/ml,PBS pH 7.2: 25 mg/ml
form :Liquid
color :Colorless to light yellow
Water Solubility :Water: 30 mg/ml
solubility :DMF: 10 mg/ml,DMSO: 10 mg/ml,Ethanol: 10 mg/ml,PBS pH 7.2: 25 mg/ml
form :Liquid
color :Colorless to light yellow
Water Solubility :Water: 30 mg/ml
Safety Information
Symbol(GHS): |
![]() ![]() |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||
Precautionary statements: |
|